|
|
 |
NAYZILAM Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
NEVANAC Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
NEURACEQ Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALBUMIN HUMAN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
NEUPRO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|